W Wynendaele
Overview
Explore the profile of W Wynendaele including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
225
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lambert E, Hollebosch S, Van Praet C, Van Bruwaene S, Duck L, De Roock W, et al.
Acta Clin Belg
. 2021 Nov;
77(6):897-905.
PMID: 34789066
Introduction: Abiraterone acetate + prednisone (AAP) and docetaxel have proven their efficacy in the treatment of patients with newly diagnosed metastatic hormone-sensitive prostate cancer (mHSPC) in clinical trials. However, real-world...
2.
Janus N, Launay-Vacher V, Byloos E, Machiels J, Duck L, Kerger J, et al.
Br J Cancer
. 2010 Nov;
103(12):1815-21.
PMID: 21063408
Background: half of anticancer drugs are predominantly excreted in urine. Dosage adjustment in renal insufficiency (RI) is, therefore, a crucial issue. Moreover, patients with abnormal renal function are at high...
3.
Wildiers H, Neven P, Christiaens M, Squifflet P, Amant F, Weltens C, et al.
Ann Oncol
. 2010 Aug;
22(3):588-594.
PMID: 20709813
Background: To evaluate capecitabine-docetaxel (XT), with trastuzumab (H) in human epidermal growth factor receptor 2 (HER2)-positive disease, in inoperable locally advanced breast cancer (LABC). Patients And Methods: Patients received up...
4.
Wildiers H, Fontaine C, Vuylsteke P, Martens M, Canon J, Wynendaele W, et al.
Breast Cancer Res Treat
. 2010 Jul;
123(2):463-9.
PMID: 20652398
The aim of this study is to test the hypothesis that antiangiogenic treatment with sunitinib consolidation can prolong remissions induced by taxane-based chemotherapy in women with metastatic breast cancer. The...
5.
Castryck H, Van den Driessche M, Hagemeijer A, Stul M, Wynendaele W, Vandenberghe P, et al.
Clin Lab Haematol
. 2006 Apr;
28(2):138-40.
PMID: 16630221
We report on a 48-year-old man with concomitantly diagnosed kappa expressing chronic lymphocytic leukaemia (CLL) and lambda light chain disease with highly complex chromosomal aberrations. The clinical course of the...
6.
Ismail M, Wynendaele W, Aerts J, Paridaens R, Van Mellaert L, Anne J, et al.
Ann Oncol
. 2003 Jul;
14(8):1241-5.
PMID: 12881386
Background: We previously developed a real-time quantitative RT-PCR technique to detect breast carcinoma cells in peripheral blood (PB). The aim of the current study was to improve cytokeratin 19 (CK19)...
7.
Eskens F, Dumez H, Hoekstra R, PERSCHL A, Brindley C, Bottcher S, et al.
Eur J Cancer
. 2003 Apr;
39(7):917-26.
PMID: 12706360
A single-agent dose escalating phase I and pharmacokinetic study with Cilengitide, an inhibitor of the integrins alphavbeta3 and alphavbeta5, was performed to determine its safety and toxicity. Cilengitide was administered...
8.
Groen H, De Vries E, Wynendaele W, van der Graaf W, Fokkema E, Lechuga M, et al.
Clin Cancer Res
. 2001 Dec;
7(12):3928-33.
PMID: 11751484
Our aim was to establish, in patients with solid tumors, the dose-limiting toxicity, maximum tolerated dose (MTD), and pharmacology of PNU-145156E, a new sulfonated distamycin A derivative that blocked circulating...
9.
Aerts J, Wynendaele W, Paridaens R, Christiaens M, Van Den Bogaert W, Van Oosterom A, et al.
Ann Oncol
. 2001 Mar;
12(1):39-46.
PMID: 11249047
Background: The detection of occult carcinoma cells in patients with breast cancer has been shown to predict disease recurrence and metastasis. Materials And Methods: To improve on molecular detection of...
10.
Landuyt W, Verdoes O, Darius D, Drijkoningen M, Nuyts S, Theys J, et al.
Eur J Cancer
. 2000 Sep;
36(14):1833-43.
PMID: 10974632
Tumour-specific vascularisation may be therapeutically approached in two different ways: by antiangiogenic treatments specifically directed to dividing and migrating endothelial cells, or by agents that target principally the inadequate and...